Wafra Inc. Exact Sciences Corp Transaction History

Wafra Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$48.29 - $80.6 $8.42 Million - $14.1 Million	-174,339 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $4.59 Million - $6.63 Million	115,159 Added 194.59%	174,339 $7.03 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $3.64 Million - $4.74 Million	-78,297 Reduced 56.95%	59,180 $3.11 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $5.09 Million - $6.48 Million	137,477	137,477 $6.48 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.